Products & Services

Dr. Ashley Tuan Discusses VTI’s PROTECT Trial

sponsored content

October 17, 2023

Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies Inc. (VTI) at the 2023 American Academy of Optometry Annual Meeting.

Following her presentation on the one-year results of VTI’s PROTECT Trial (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial), Dr. Tuan shared the specifics on the one-year findings, why these results are encouraging and important, the future of NaturalVue Multifocal contact lenses, and more.

Watch the full discussion here:

To Top